Skip to main content
OpenTrials

Clinical trial condition

Solitary Fibrous Tumors

Explore clinical trials studying Solitary Fibrous Tumors. Study availability and eligibility vary by location and protocol.

11 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Solitary Fibrous Tumors trial results

Recruiting

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

NCT06239272

Conditions
Adipocytic Neoplasm, Angiomatoid Fibrous Histiocytoma, Angiosarcoma, +60 more
Locations
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Our Lady of the Lake Children's Hospital Baton Rouge, Louisiana, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

NCT06789172

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +49 more
Locations
  • Precision NextGen Oncology and Research Center Beverly Hills, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Chris O'Brien Lifehouse Sydney, New South Wales, Australia
View Trial Details
Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

NCT04094610

Conditions
Astrocytoma, Glioblastoma, Glioma, +30 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • Children's Hospital Colorado - Anschutz Medical Campus Aurora, Colorado, United States
  • Local Institution - 2105 Orlando, Florida, United States
View all 68 locations
View Trial Details
Completed

Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor

NCT03023124

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective Tissue, +3 more
Locations
  • Nuovo Ospedale di Prato Prato, Firenze, Italy
  • Fondazione IRCCS Istituto Nazionale dei Tumori Milan, MI, Italy
  • Policlinico Universitario Campus Biomedico Roma, RM, Italy
  • IRCCS Istituto ortopedico Rizzoli Bologna, Italy
View Trial Details
Completed

Eribulin in Advanced Solitary Fibrous Tumor

NCT03840772

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective Tissue, +5 more
Locations
  • Azienda Ospedaliera Universitaria Paolo Giaccone Palermo, PA, Italy
  • Policlinico Universitario Campus Biomedico Roma, RM, Italy
  • Fondazione IRCCS INT Milano Milan, Italy
View Trial Details
Completed

Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas

NCT03277924

Conditions
Bone Diseases, Bone Neoplasms, Bone Sarcoma, +27 more
Locations
  • Istituto Ortopedico Rizzoli Bologna, Italy
  • Candiolo Cancer Institute - FPO, IRCCS Candiolo, Italy
  • Istituto Nazionale dei Tumori Milan, Italy
  • Hospital Universitario Fundación Jiménez Díaz Madrid, Spain
View all 13 locations
View Trial Details
Completed

Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma

NCT02066285

Conditions
Chondrosarcoma, Extraskeletal Myxoid, Extraskeletal Myxoid Chondrosarcoma, Neoplasm Metastasis, +10 more
Locations
  • H. Son Espases Palma de Mallorca, Balearic Islands, Spain
  • H. Universitario de Canarias Santa Cruz de Tenerife, Santa Cruz De Tenerife, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
  • Hospital La Paz Madrid, Spain
View Trial Details
Completed

Trial of Dasatinib in Advanced Sarcomas

NCT00464620

Conditions
Chondrosarcoma, Chordoma, Digestive System Diseases, +37 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Cedars-Sinai Outpatient Cancer Center Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
View all 20 locations
View Trial Details

Related conditions